📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Farapulse

1.1 - Company Overview

Farapulse Logo

Farapulse

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of catheter-based pulsed field ablation tools to treat atrial fibrillation, including the FARAPULSE PFA System that selectively ablates cardiac tissue with pulsed electric fields to minimize damage to surrounding tissues; the FARAWAVE catheter for pulmonary vein isolation in paroxysmal AF; the FARADRIVE steerable sheath for percutaneous catheter introduction; and the FARASTAR generator delivering pulsed fields.

Products and services

  • FARAPULSE™ Pulsed Field Ablation (PFA) System: A catheter-based system that treats atrial fibrillation by selectively ablating cardiac tissue using pulsed electric fields while minimizing damage to surrounding tissues
  • FARASTAR™ Pulsed Field Ablation Generator: A system-integrated generator that delivers pulsed electric fields for the isolation of pulmonary veins in atrial fibrillation treatment as part of the FARAPULSE PFA System
  • FARAWAVE™ Pulsed Field Ablation Catheter: A PFA-enabled catheter used within the FARAPULSE PFA System to isolate pulmonary veins in the treatment of paroxysmal atrial fibrillation

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Farapulse

Zerusa Logo

Zerusa

HQ: Ireland Website
  • Description: Provider of minimally invasive medical devices for the diagnosis and treatment of vascular disease, designed, developed, and marketed by Zerusa Limited.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zerusa company profile →
Huyabio Logo

Huyabio

HQ: United States Website
  • Description: Provider of novel biopharmaceutical product opportunities, including HBI-8000, an oral class I selective HDAC inhibitor for cancers; HBI-3000, a multi-ion channel blocker for atrial fibrillation; HBI-2376, an SHP2 inhibitor for solid tumors; HBI-ONC, an epigenetic inhibitor for MDS/AML; and HBI-3800, a small molecule to regenerate cardiac muscle damaged by ischemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Huyabio company profile →
Arterial Remodeling Technologies Logo

Arterial Remodeling Technologies

HQ: France Website
  • Description: Provider of bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of injured arteries after angioplasty.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arterial Remodeling Technologies company profile →
CV Ingenuity Logo

CV Ingenuity

HQ: United States Website
  • Description: Provider of drug-coated balloon platforms for the “Touch-and-Go” treatment of vascular diseases, developing devices to relieve vascular obstructions, inhibit restenosis, and enable natural vessel healing; Palo Alto, CA-based.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CV Ingenuity company profile →
Thoratec Logo

Thoratec

HQ: United States Website
  • Description: Provider of mechanical circulatory support medical devices for patients with advanced heart failure. A world leader with the broadest product portfolio, including HeartMate LVAS and Thoratec VAD, addressing the full range of clinical needs, with more than 20,000 devices implanted.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Thoratec company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Farapulse

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Farapulse

2.2 - Growth funds investing in similar companies to Farapulse

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Farapulse

4.2 - Public trading comparable groups for Farapulse

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Farapulse

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Farapulse

What does Farapulse do?

Farapulse is a provider of catheter-based pulsed field ablation tools to treat atrial fibrillation, including the FARAPULSE PFA System that selectively ablates cardiac tissue with pulsed electric fields to minimize damage to surrounding tissues; the FARAWAVE catheter for pulmonary vein isolation in paroxysmal AF; the FARADRIVE steerable sheath for percutaneous catheter introduction; and the FARASTAR generator delivering pulsed fields.

Who are Farapulse's competitors?

Farapulse's competitors and similar companies include Zerusa, Huyabio, Arterial Remodeling Technologies, CV Ingenuity, and Thoratec.

Where is Farapulse headquartered?

Farapulse is headquartered in United States.

How many employees does Farapulse have?

Farapulse has 1,000 employees 🔒.

When was Farapulse founded?

Farapulse was founded in 2010 🔒.

What sector and industry vertical is Farapulse in?

Farapulse is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Farapulse

Who are the top strategic acquirers in Farapulse's sector and industry

Top strategic M&A buyers and acquirers in Farapulse's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Farapulse?

Top strategic M&A buyers groups and sectors for Farapulse include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Farapulse's sector and industry vertical

Which are the top PE firms investing in Farapulse's sector and industry vertical?

Top PE firms investing in Farapulse's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Farapulse's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Farapulse's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Farapulse's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Farapulse include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Farapulse's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Farapulse?

The key public trading comparables and valuation benchmarks for Farapulse include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Farapulse for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Farapulse with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Farapulse's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Farapulse with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Farapulse's' sector and industry vertical?

Access recent funding rounds and capital raises in Farapulse's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Farapulse